Solara Active Pharma Sciences Ltd.
NSE: SOLARA | BSE: 541540
₹579.90
As on 15-May-2026IST
Market cap
₹2,791 Cr
Revenue (TTM)
₹1,369 Cr
P/E Ratio
--
P/B Ratio
2.2
Div. Yield
0 %
Quality Score
1/10
Growth Score
5/10
Valuation Score
2/10
Momentum Score
6/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-7 Cr
-
ROE
0.1 %
-
ROCE
6.1 %
-
Industry P/E
38.14
-
EV/EBITDA
17.7
-
Debt to Equity
0.1
-
Book Value
₹257.6
-
EPS
₹-0.3
-
Face value
10
-
Shares outstanding
48,171,562
8 Years Aggregate
CFO
₹849.07 Cr
EBITDA
₹1,253.56 Cr
Net Profit
₹-238.03 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Solara Active
| 2.6 | 19.6 | 16.1 | 0.7 | 15.6 | -18.2 | -- |
|
BSE Healthcare
| 8.7 | 11.0 | 10.7 | 11.7 | 26.8 | 14.4 | 11.8 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Solara Active
| -19.5 | 105.0 | -16.1 | -57.8 | -14.9 | 179.1 | 40.6 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Solara Active
|
579.9 | 2,791.3 | 1,369.0 | -7.4 | 6.4 | -0.1 | -- | 2.2 |
| 1,044.6 | 12,824.4 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.7 | 3.8 | |
| 430.4 | 7,458.2 | 1,053.1 | 293.6 | 32.3 | 24.6 | 25.4 | 5.8 | |
| 1,135.3 | 11,839.4 | 1,158.7 | 309.6 | 31.9 | 17.3 | 37.9 | 6.3 | |
| 1,704.9 | 32,273.8 | 9,203.5 | 941.3 | 15.4 | 19.6 | 34.9 | 6.5 | |
| 370.3 | 4,048.6 | 159.3 | 47.8 | 39.0 | 18.6 | 84.7 | 14.6 | |
| 16,590.0 | 21,132.6 | 2,023.0 | 364.0 | 23.9 | 20.8 | 58.1 | 11.3 | |
| 1,050.4 | 4,831.3 | 649.5 | 121.6 | 23.7 | 13.2 | 41.9 | 5.2 | |
| 649.0 | 7,364.3 | 502.0 | 138.7 | -- | 32.8 | 53.1 | 8.5 | |
| 211.2 | 5,588.2 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 9.4 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Solara Active
Solara Active Pharma Sciences Limited manufactures, produces, processes, formulates, sells, imports, exports, merchandises, distributes, trades in, and deals in active pharmaceutical ingredients (API) in India, Asia Pacific, Europe, North America,... South America, and internationally. The company offers APIs for amyotrophic lateral sclerosis, anesthetics, anthelmintic, anti hyperlipidemic, anti-arrhythmic agent, anti-asthmatic, anti-hypertensive, anti-inflammatory, anti-Parkinson, anti-retroviral, antibiotic, anticonvulsant, antidepressant, antifibrinolytics, antigout agent, antihelmintic, antihistamine, antihyperlipoproteinemic, antimycotic, antifungal, antineoplastic detoxifying agent, antiprotozoal agent, antipsoriatic, antipsychotic, antitubercular, antiulcer, antiulcerative, anxiolytic, aprepitant, bile acid analogue, calcimimetic agent, cardiovascular agent, chronic alcoholism, treatment of hyperphosphatemia, hemorrheologic agent, hypercholesterolemia, hypophosphatemic agent, immune-suppressant, loop diuretic, NSAIDs, anti-hyperkalaemia, nucleoside inhibitor, OAB treatment, phenylalanine reducer, phosphate binder, reversal of neuro-muscular blocking agent, skeletal muscle relaxant, and topical anti-infectives. It also provides contract research and manufacturing services for APIs, including contract development and manufacturing, analytical development, impurity synthesis, and regulatory support. In addition, the company exports its products. The company was formerly known as SSL Pharma Sciences Limited and changed its name to Solara Active Pharma Sciences Limited in March 2017. Solara Active Pharma Sciences Limited was incorporated in 2017 and is based in Chennai, India. Read more
-
Incorporated
2017
-
Chairman
R Ramakrishnan
-
Managing Director
Sandeep Rao
-
Headquarters
Navi Mumbai, Maharashtra
-
Website
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation In Relation To The Rights Issue
15-May-2026No News & Announcements are available.
FAQs for Solara Active
What is the current share price of Solara Active Pharma Sciences Ltd Today?
The share price of Solara Active Pharma Sciences Ltd is ₹579.90 (NSE) and ₹579.45 (BSE) as of 15-May-2026 IST. Solara Active Pharma Sciences Ltd has given a return of 15.6% in the last 3 years.
What is the current PB & PE ratio of Solara Active Pharma Sciences Ltd?
Since, TTM earnings of Solara Active Pharma Sciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Solara Active Pharma Sciences Ltd is 2.25 times as on 15-May-2026, a 22 discount to its peers’ median range of 2.89 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
3,820.42
|
1.89
|
|
2024
|
0.00
|
1.44
|
|
2023
|
0.00
|
0.79
|
|
2022
|
0.00
|
1.57
|
|
2021
|
22.63
|
3.16
|
What is the 52 Week High and Low of Solara Active Pharma Sciences Ltd?
The 52-week high and low of Solara Active Pharma Sciences Ltd are Rs 734.40 and Rs 422.00 as of 15-May-2026.
What is the market cap of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd has a market capitalisation of ₹ 2,791 Cr as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Solara Active Pharma Sciences Ltd?
Before investing in Solara Active Pharma Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.